sglt2 inhibitors vs glp 1 GLP1 Receptor Agonists SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog The effect of DPP-4 inhibitors,

29 Another valuable study would be a prospective randomized clinical trial with well-designed primary ocular outcomes comparing the GLP-1/GIP agonists to another diabetes drug class, such as the SLGT inhibitors, which has the same target hemoglobin A1c reduction in both treatment arms

The participants had underlying health conditions, including diabetes, non-alcoholic steatohepatitis, knee osteoarthritis, or were undergoing hemo-dialysis

Kochupillai V

Interested in long-term healthy aging

There will be minimal effects on insulin and glucagon production, as both are already significantly impaired in type 1 diabetes, and slowing gastric emptying is not an obvious advantage